Overall, studies are in agreement with the fact that miRs are potential upstream mediators of the STAT3 signaling pathway in GC and the modulation of the miR/STAT3 axis can lead to effective GC therapy (Table 3, Figure 2 and Figure 3). This evidence concerns the gene STAT3 and gastric cancer.